CRYOTHERAPY

PreclinicalSmall molecule

AAssistance Publique - Hôpitaux de Paris

CRYOTHERAPY is one of 4 small molecule programs targeting Common Wart. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Common WartActive, not recruiting

Common WartPreclinical

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Common Wart

#DrugCompanyPhaseTrials

Vistide

Trexall

CRYOTHERAPY

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 4

Candida Antigen

UUniversity of Arkansas

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Plantar Wart1 trial

Comparison of Five Treatments in Patients With Plantar Warts

Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT01059110·358 enrolled

Cryotherapy1 trial

Cryotherapy as a Topical Anesthetic in Healthy Children

Completed·OOndokuz Mayıs University·Phase 4·NCT07198022·100 enrolled

Common Wart1 trial

Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts

Completed·—·N/A·NCT05712811·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for CRYOTHERAPY. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — CRYOTHERAPY compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for CRYOTHERAPY. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

CRYOTHERAPY

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Plantar Wart1 trial

Cryotherapy1 trial

Common Wart1 trial

References

Drug Info

Quick Facts

Related News